Back to top
more

Inspire Medical Systems (INSP)

(Delayed Data from NYSE)

$61.44 USD

61.44
517,994

+0.62 (1.02%)

Updated Aug 28, 2026 04:00 PM ET

After-Market: $61.51 +0.07 (0.11%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.80%
2Buy18.13%
3Hold10.19%
4Sell5.73%
5Strong Sell3.17%
S&P50011.53%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth B Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 31% (77 out of 248)

Industry: Medical Info Systems

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Sridatri Sarkar headshot

TEM's Stable Solvency and Financial Strength Are Gaining Attention

by Sridatri Sarkar

Tempus AI posts a strong Q3 2025 balance sheet with $760M cash, no current debt, and positive adjusted EBITDA, boosting flexibility and solvency.

Zacks Equity Research

Here's Why You Should Retain INSP Stock in Your Portfolio Now

by Zacks Equity Research

INSP's Inspire V gains traction with strong clinical data, improving reimbursement visibility and cost control, even as inventory and GLP-1 headwinds persist.

Zacks Equity Research

Why Is Tempus (TEM) Down 8.9% Since Last Earnings Report?

by Zacks Equity Research

Tempus (TEM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Why Is Inspire (INSP) Up 57.6% Since Last Earnings Report?

by Zacks Equity Research

Inspire (INSP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Are Options Traders Betting on a Big Move in INSP Stock?

by Zacks Equity Research

Investors need to pay close attention to Inspire Medical Systems stock based on the movements in the options market lately.

Zacks Equity Research

INSP Stock Gains Following Q3 Earnings Beat, Gross Margin Expands

by Zacks Equity Research

Inspire Medical tops third-quarter 2025 estimates as revenue climbs and gross margin improves, with full-year EPS guidance raised.

Zacks Equity Research

Inspire (INSP) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

by Zacks Equity Research

While the top- and bottom-line numbers for Inspire (INSP) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks Equity Research

Inspire Medical Systems (INSP) Tops Q3 Earnings and Revenue Estimates

by Zacks Equity Research

Inspire (INSP) delivered earnings and revenue surprises of +353.33% and +1.61%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Indrajit Bandyopadhyay headshot

3 MedTech Stocks Positioned to Surpass Q3 Earnings Estimates

by Indrajit Bandyopadhyay

Despite tariff and inflation pressures, innovation-fueled momentum in diabetes care, surgical tech, and cardiovascular devices could drive upside surprises for SOLV, COR and INSP this earnings season.

Debanjana Dey headshot

Can Sustained Product Demand Drive HIMS Stock Before Q3 Earnings?

by Debanjana Dey

Hims & Hers benefits from strong platform engagement and hormonal health launches ahead of third-quarter 2025 earnings.